Cargando…

Cancer Cell Signalling.

A focused, accessible introduction to this key aspect of cancer biology. It covers the individual cell signalling pathways that are known to be involved in cancer development, and, most important, includes the cross- interactions between the pathways together with the current therapeutic approaches....

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Harvey, Amanda
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken : Wiley, 2013.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn862822866
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 131111s2013 xx ob 001 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d K6U  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d ZCU  |d MERUC  |d OCLCQ  |d U3W  |d STF  |d ICG  |d OCLCQ  |d TKN  |d DKC  |d OCLCQ  |d UKAHL  |d HS0  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 9781118527832 
020 |a 1118527836 
020 |z 9781119967569  |q (cloth) 
020 |z 9781119967576  |q (pbk.) 
029 1 |a DEBBG  |b BV044063324 
035 |a (OCoLC)862822866 
050 4 |a RC268.5 
060 1 0 |a QZ 202 
082 0 4 |a 616.99  |a 616.994 
049 |a UAMI 
100 1 |a Harvey, Amanda. 
245 1 0 |a Cancer Cell Signalling. 
260 |a Hoboken :  |b Wiley,  |c 2013. 
300 |a 1 online resource (230 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
504 |a Includes bibliographical references and index. 
505 0 |a Cover; Title Page; Copyright; Contents; List of contributors; Acknowledgements; Introduction; About the companion website; Chapter 1 Epidermal growth factor receptor family; 1.1 ErbB receptors and their structure; 1.2 ErbB ligands; 1.2.1 Ligand production; 1.2.2 Effects of ligand binding to receptors; 1.3 Downstream signalling molecules and events; 1.4 Signalling regulation; 1.4.1 Regulation of phosphorylation events; 1.4.2 Internalisation of receptors; 1.5 Dysregulation of signalling in cancer; 1.5.1 Receptor over-expression; 1.5.2 Activating mutations; 1.5.3 Altered cellular localisation 
505 8 |a 1.5.4 Changes in ligand levels1.5.5 Changes in adaptor protein levels; 1.6 Therapeutic opportunities; 1.6.1 Current strategies; 1.6.2 Future strategies; References; Chapter 2 Insulin and the insulin-like growth factor (IGF) family; 2.1 Receptors; 2.2 Ligands; 2.2.1 Types of ligands; 2.2.2 Ligand binding affinities; 2.2.3 Insulin growth factor binding proteins (IGFBPs); 2.3 Downstream signalling molecules and events; 2.4 Dysregulation of signalling in cancer; 2.4.1 Over-expression and activation of receptors; 2.5 Therapeutic opportunities; 2.5.1 Targeting receptors; 2.5.2 Targeting ligands 
505 8 |a 3.6.2 Anti-sense oligonucleotides3.6.3 Small molecule inhibitors; 3.6.4 Signalling pathway inhibitors; References; Chapter 4 Wnt signalling; 4.1 Introduction and overview; 4.2 The ligands: Wnt proteins, their modification and secretion; 4.3 The receptors: Frizzleds and LRPs, multiple receptors and combinations; 4.4 Regulation of signalling; 4.4.1 Extracellular Wnt antagonists: turning the signalling off at the source; 4.4.2 Intracellular regulation; 4.5 When good signalling goes bad: Wnt signalling in diseases; 4.6 Taming the beast: drugs and small molecule inhibitors targeting Wnt signalling 
505 8 |a 4.7 Conclusion and perspectivesReferences; Chapter 5 Mammalian target of rapamycin (mTOR) signalling; 5.1 Discovery of mTOR; 5.2 mTOR complexes; 5.2.1 mTORC1; 5.2.2 mTORC2; 5.2.3 Complexes Upstream of mTOR; 5.2.4 Downstream signalling effectors; 5.3 mTOR dysregulation in disease; 5.3.1 Dysregulation of mTOR in cancers; 5.3.2 Dysregulation of mTOR signalling in gynaecological malignancies; 5.4 Therapeutic opportunities; 5.4.1 Current treatments; 5.4.2 Future opportunities; References; Chapter 6 c-Met receptor signalling; 6.1 Historical context -- identification of the MET gene 
520 |a A focused, accessible introduction to this key aspect of cancer biology. It covers the individual cell signalling pathways that are known to be involved in cancer development, and, most important, includes the cross- interactions between the pathways together with the current therapeutic approaches. This is a 'must-have' for advanced undergraduate and postgraduate students studying and researching within the field of cancer biology. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Cancer  |x Molecular aspects. 
650 0 |a Carcinogenesis. 
650 2 |a Carcinogenesis 
650 6 |a Cancer  |x Aspect moléculaire. 
650 6 |a Cancérogenèse. 
650 7 |a Cancer  |x Molecular aspects  |2 fast 
650 7 |a Carcinogenesis  |2 fast 
758 |i has work:  |a Cancer cell signalling (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCG3xrxwg8kQwFvrMM96fG3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Harvey, Amanda.  |t Cancer Cell Signalling.  |d Hoboken : Wiley, ©2013  |z 9781119967576 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1390825  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH25741646 
938 |a Askews and Holts Library Services  |b ASKH  |n AH25741664 
938 |a EBL - Ebook Library  |b EBLB  |n EBL1390825 
994 |a 92  |b IZTAP